Sekisui XenoTech Overview

  • Founded
  • 1994
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Sekisui XenoTech General Information

Description

Provider of healthcare research services. The company performs tests on non transplantable human livers to find out how drugs metabolized in humans.

Contact Information

Formerly Known As
Xenotech
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • 1101 West Cambridge Circle Drive
  • Kansas City, MO 66103
  • United States
+1 (877) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sekisui XenoTech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sekisui XenoTech‘s full profile, request access.

Request a free trial

Sekisui XenoTech Executive Team (5)

Name Title Board Seat Contact Info
Yasuhisa Adachi Ph.D Chief Executive Officer
Jason Neat Chief Operating Officer
David Buckley Ph.D Chief Scientific Officer
Andrew Parkinson Founder
You’re viewing 4 of 5 executive team members. Get the full list »